Seppo Ylä-Herttuala
Corporate Officer/Principal bei University of Kuopio
Aktive Positionen von Seppo Ylä-Herttuala
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of Kuopio | Corporate Officer/Principal | 24.11.2010 | - |
Karriereverlauf von Seppo Ylä-Herttuala
Ehemalige bekannte Positionen von Seppo Ylä-Herttuala
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 11.09.2009 | 15.03.2013 |
Gründer | 11.09.2009 | 15.03.2013 | |
Corporate Officer/Principal | 11.09.2009 | 15.03.2013 | |
FinVector Oy
FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Gründer | 01.01.1993 | - |
Ausbildung von Seppo Ylä-Herttuala
University of Tampere | Doctorate Degree |
Statistik
International
Finnland | 4 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 2 |
Founder | 2 |
Director/Board Member | 1 |
Sektoral
Consumer Services | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
FinVector Oy
FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Health Technology |
- Börse
- Insiders
- Seppo Ylä-Herttuala
- Erfahrung